Leber Congenital Amaurosis Lca clinical trials

Explore recruiting leber congenital amaurosis lca clinical trials.

Recruiting leber congenital amaurosis lca studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Leber Congenital Amaurosis Lca trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-Masked, Randomized, Placebo-Controlled, Paired Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subjects with Leber Congenital Amaurosis (LCA) due to the c.2991+1655A>G (p.Cys998X) Mutation in the CEP290 Gene

Netherlands, Belgium, France, Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Leber Congenital Amaurosis Lca trials by city

Leber Congenital Amaurosis Lca in Toronto Leber Congenital Amaurosis Lca in Vancouver Leber Congenital Amaurosis Lca in Montreal Leber Congenital Amaurosis Lca in Calgary Leber Congenital Amaurosis Lca in Edmonton Leber Congenital Amaurosis Lca in Ottawa Leber Congenital Amaurosis Lca in Winnipeg Leber Congenital Amaurosis Lca in Quebec City Leber Congenital Amaurosis Lca in Hamilton Leber Congenital Amaurosis Lca in Kitchener Leber Congenital Amaurosis Lca in London Leber Congenital Amaurosis Lca in Halifax Leber Congenital Amaurosis Lca in New York Leber Congenital Amaurosis Lca in Los Angeles Leber Congenital Amaurosis Lca in Chicago Leber Congenital Amaurosis Lca in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease